Your session is about to expire
← Back to Search
Diagnostic Device
Ultrasound with Shearwave Elastography for Carpal Tunnel Syndrome
N/A
Waitlist Available
Led By Azra Alizad, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 18 years old
Scheduled for corticosteroid injection or surgery
Must not have
Individuals less than 18 years of age
Prior surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 to 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new ultrasound method to check for stiffness and other issues in the wrists of patients, especially after treatments like surgery or injections. The ultrasound uses sound waves to take detailed pictures of the inside of the wrist.
Who is the study for?
This trial is for adults over 18 with wrist pain from Carpal Tunnel Syndrome in one wrist, who are scheduled for a corticosteroid injection or surgery. It's not suitable for those under 18, anyone who has had previous wrist surgery, or individuals with symptoms in both wrists.
What is being tested?
The study tests a new ultrasound technique using shear wave elastography to detect stiffness in the nerve and tissues of the affected wrist before and after treatment.
What are the potential side effects?
Since this trial involves an ultrasound system which is non-invasive, there are minimal risks involved. However, some discomfort during the imaging process due to pressure on the sensitive area may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am scheduled for a corticosteroid injection or surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am under 18 years old.
Select...
I have had surgery before.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 to 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 to 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Evaluate the treatment response by shear wave elastography (SWE)
Secondary study objectives
Correlate shear wave elastography (SWE) measurements with patient-reported measures of symptom severity and functional status scores and severity of pre-operative electrodiagnostic tests (EDX) elasticity
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Operative treatment (surgical decompression) for carpal tunnel syndromeExperimental Treatment1 Intervention
Shear wave elastography (SWE) will be used to assess the stiffness of tissue. Patients will be revaluated at 3 and 6 months post-operatively. Patient will sit done in a chair. The investigators will scan the wrist area of both arms to acquire SWE map. This imaging will be done before the treatment. We will repeat the imaging study at 3 and 6 months after the treatment. Each ultrasound imaging session will take about less than 10 min. The investigators do not expect any discomfort during the imaging.
Group II: Corticosteroid injection treatment for carpal tunnel syndromeExperimental Treatment1 Intervention
Shear wave elastography (SWE) will be used to assess the stiffness of tissue. Patients will be revaluated after 6 weeks following corticosteroid injection. Patient will sit done in a chair. The investigators will scan the wrist area of both arms to acquire SWE map. The investigators do not expect any discomfort during the imaging.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Carpal Tunnel Syndrome (CTS) aim to reduce pressure on the median nerve within the carpal tunnel. Splinting keeps the wrist in a neutral position to minimize nerve compression, while corticosteroid injections reduce inflammation and swelling, thereby decreasing pressure on the nerve.
Surgical release involves cutting the transverse carpal ligament to enlarge the carpal tunnel and relieve nerve compression. The new ultrasound method being studied focuses on detecting tissue stiffness, which is crucial for diagnosing and monitoring the effectiveness of these treatments.
By identifying areas of increased stiffness, healthcare providers can better tailor interventions to reduce nerve compression and improve patient outcomes.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,353 Previous Clinical Trials
3,061,003 Total Patients Enrolled
9 Trials studying Carpal Tunnel Syndrome
1,016 Patients Enrolled for Carpal Tunnel Syndrome
Azra Alizad, MDPrincipal InvestigatorMayo Clinic
5 Previous Clinical Trials
3,050 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- People who are considered to be at higher risk or needing extra protection.I have pain in one of my wrists.I am under 18 years old.Experiencing symptoms on both sides of the body.I have had surgery before.I am either male or female.I am 18 years old or older.I am scheduled for a corticosteroid injection or surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Operative treatment (surgical decompression) for carpal tunnel syndrome
- Group 2: Corticosteroid injection treatment for carpal tunnel syndrome
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.